Health Products (Licensing of Retail Pharmacies) (Amendment) Regulations 2023

Status:

Published in Subsidiary Legislation Supplement
on 23 Jun 2023

No. S 433

Health Products Act 2007

Health Products
(Licensing of Retail Pharmacies)
(Amendment) Regulations 2023

In exercise of the powers conferred by section 72 of the Health Products Act 2007, the Health Sciences Authority, with the approval of the Minister for Health, makes the following Regulations:

Citation and commencement

1.—(1) These Regulations are the Health Products (Licensing of Retail Pharmacies) (Amendment) Regulations 2023 and, except for regulation 4, come into operation on 26 June 2023.

(2) Regulation 4 is deemed to have come into operation on 31 December 2021.

Amendment of regulation 2

2. In the Health Products (Licensing of Retail Pharmacies) Regulations 2016 (G.N. No. S 330/2016) (called in these Regulations the principal Regulations), in regulation 2 —

(a)

after the definition of “application fee”, insert —

“ “approved conveyance”, “approved permanent premises” and “permanent premises” have the meanings given by section 2(1) of the Healthcare Services Act 2020;”;

(b)

replace the definition of “collaborative prescribing practitioner” with —

“ “collaborative prescribing practitioner” has the meaning given by regulation 2 of the Healthcare Services (Collaborative Prescribing Service) Regulations 2023 (G.N. No. S 398/2023);”;

(c)

after the definition of “general sale list medicine”, insert —

“ “healthcare service licensee” means a person who holds a licence under the Healthcare Services Act 2020 to provide a licensable healthcare service;”;

(d)

replace the definition of “licensed healthcare institution” with —

“ “licensable healthcare service” has the meaning given by section 3(1) of the Healthcare Services Act 2020;

“nursing home” means a nursing home within the meaning of the Private Hospitals and Medical Clinics Act 1980 that is licensed under that Act;

“nursing home licensee” means a person who holds a licence under the Private Hospitals and Medical Clinics Act 1980 to operate a nursing home;”;

(e)

replace the definition of “pharmacy department” with —

“ “personnel” means —

(a)	in relation to a healthcare service licensee providing a licensable healthcare service — any individual employed or engaged by the healthcare service licensee to assist the licensee in providing the licensable healthcare service; and
(b)	in relation to a nursing home licensee operating a nursing home — any individual employed or engaged by the nursing home licensee to assist in the operation of the nursing home;

“pharmacy department” means —

(a)	in relation to a nursing home, the part of the nursing home set aside for the supply, dispensing or compounding of therapeutic products on order or prescription to patients at the nursing home; and
(b)	in relation to a healthcare service licensee, the part of any approved permanent premises, approved conveyance or temporary premises of the healthcare service licensee set aside for the supply, dispensing or compounding of therapeutic products on order or prescription to patients at the approved permanent premises, approved conveyance or temporary premises;”; and

(f)

after the definition of “telepharmacy services”, insert —

“ “temporary premises” means any premises other than permanent premises;”.

Amendment of regulation 3

3. In the principal Regulations, in regulation 3(3), replace sub‑paragraph (a) with —

“(a)

any of the following persons who supplies a specified health product by retail sale to a patient at a nursing home, in accordance with the written instructions of a qualified practitioner or collaborative prescribing practitioner, who is a personnel of the nursing home licensee:

(i)	the nursing home licensee;
(ii)	a person who is authorised by the nursing home licensee to make that supply;

(aa)

any of the following persons who supplies a specified health product by retail sale to a patient of a healthcare service licensee in accordance with the written instructions of a qualified practitioner or collaborative prescribing practitioner, who is a personnel of the healthcare service licensee:

(i)	the healthcare service licensee;
(ii)	a person who is authorised by the healthcare service licensee to make that supply; or”.

Miscellaneous amendments

4. In the principal Regulations —

(a)

in the following provisions, replace “(Cap. 230)” with “2007”:

Regulation 2, definition of “qualified pharmacist”, paragraph (a)

Regulation 6(c);

(b)

in regulation 2, in the definition of “qualified practitioner”, in paragraph (a), replace “(Cap. 174)” with “1997”;

(c)

in regulation 2, in the definition of “qualified practitioner”, in paragraph (b), replace “(Cap. 76)” with “1999”;

(d)

in the following provisions, replace “(Cap. 185)” with “1973”:

Regulation 3(5), definition of “controlled drug”

Regulation 6(b);

(e)

in regulation 6(a), replace “(Cap. 176)” with “1975”; and

(f)

in regulation 6(d), replace “(Cap. 234)” with “1938”.

[G.N. Nos. S 120/2018; S 93/2019; S 106/2021; S 1079/2021; S 455/2022]

Made on 21 June 2023.

BENJAMIN ONG

Chairperson,
Health Sciences Authority,
Singapore.

[401:04/01-000.; MH 78:44/1; AG/LEGIS/SL/122D/2020/12 Vol. 1]

(To be presented to Parliament under section 72(5) of the Health Products Act 2007).

Search within Legislation